The EASD Annual Meeting 2022 took place in Stockholm. Photograph: PDThe EASD Annual Meeting 2022 took place in Stockholm. Photograph: PD

Diabetes: What healthcare providers and researchers really need

03.10.2022Craig Cooper

The EASD Annual Meeting is one of the largest scientific congresses, presenting the latest results from basic and clinical diabetes research and the place to meet the global diabetes community. For sure, as the Investment Director of our Swiss Diabetes Venture Fund, I was there as well. These are my takeaways

At the EASD 2022 annual meeting in Stockholm leading clinicians and researchers shared insights from various studies on diabetes technology and management, including:

  • For people with type 1 diabetes those with impaired hypoglycemia awareness self-reported about the same amount of hypoglycemia events as those with normal awareness but in reality those with hypoglycemia unawareness experienced significantly higher rates of such events, with many only detected by continuous glucose monitors (CGMs)
  • CGMs may also reduce hospitalization for acute diabetes-related events for people with type 2 diabetes on insulin, including diabetic ketoacidosis or severe hypoglycemia, when comparing hospitalization rate for a twelve-month period pre-CGM and up to two years after
  • But wider accessibility and strategies are needed for healthcare providers and researchers to use such data to advance care, including use of digital tools to monitor targets, to enable communication with healthcare providers, telemedicine and e-prescriptions, and to inform decision-making
  • People with diabetes may have higher rates of anxiety, women with diabetes are more likely to report anxiety, anxiety may be more common among younger adults with diabetes, and people with lower time-in-range may have greater anxiety; hence the importance of mental health support, as treatments including digital tools can support mental health for people with diabetes.

Not to forget: With Swiss Diabetes Venture Fund's partner, the DCB, we co-hosted a dinner at the ABBA Museum convening more than fifty key stakeholders from across the diabetes technology world including startups, medtech strategics, investors, researchers and leading figures from the diabetes community.  A truly memorable and inspirational evening among great company, we look forward to continuing the conversation at ATTD in Berlin in February 2023.

Similar Articles

17.06.2025

Redstone and Swiss Ventures Group join forces to democratize venture capital as an asset class in Switzerland

28.05.2025

LOXO Integrates Aeva’s 4D LiDAR for Safer Autonomy

29.04.2025

Arda Biomaterials Closes USD 5.25m Funding Round

01.04.2025

biped.ai Device Gains Public Reimbursement in France

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

Your cookie preferences have been saved.